GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
2.100
-0.110 (-4.98%)
At close: Jun 2, 2026, 4:00 PM EDT
2.070
-0.030 (-1.43%)
Pre-market: Jun 3, 2026, 6:14 AM EDT
GeoVax Labs Employees
GeoVax Labs had 19 employees as of December 31, 2025. The number of employees increased by 2 or 11.76% compared to the previous year.
Employees
19
Change (1Y)
2
Growth (1Y)
11.76%
Revenue / Employee
$44,857
Profits / Employee
-$1,124,686
Market Cap
6.07M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 19 | 2 | 11.76% | 19 | 0 |
| Dec 31, 2024 | 17 | 0 | - | 17 | 0 |
| Dec 31, 2023 | 17 | 3 | 21.43% | 17 | 0 |
| Dec 31, 2022 | 14 | 3 | 27.27% | 14 | 0 |
| Dec 31, 2021 | 11 | 2 | 22.22% | 11 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 41 |
| Aptevo Therapeutics | 33 |
| Cardio Diagnostics Holdings | 17 |
| FibroBiologics | 15 |
| Processa Pharmaceuticals | 12 |
| Purple Biotech | 10 |
| XTL Biopharmaceuticals | 10 |
| Can-Fite BioPharma | 5 |
GOVX News
- 5 days ago - GeoVax Labs Transcript: Investor update - Transcripts
- 7 days ago - GeoVax Labs discontinues development of COVID-19 vaccine candidate - TheFly
- 7 days ago - Roth Capital ‘strongly’ agrees with GeoVax ending COVID-19 development - TheFly
- 7 days ago - GeoVax Labs files to sell 7.64M shares of common stock for holders - TheFly
- 7 days ago - GeoVax Labs Registration statement: Registration filing - Filings
- 14 days ago - 3 Penny Stocks to Watch Now, 5/19/26 - TipRanks
- 15 days ago - GeoVax Labs Proxy statement: Proxy filing - Filings
- 19 days ago - GeoVax Labs Quarterly report: Q1 2026 - Filings